Request Trial
shutterstock_1231106194_pajor_pawel
Pajor Pawel / Shutterstock.com
1 February 2021Rory O'Neill

LSPN Connect: how COVID crystallised Oxford Uni’s licensing mission

The COVID-19 pandemic has brought into sharp relief the crucial role that universities play in cutting-edge innovation. One story of the past year is the collaboration between research institutions such as Oxford University, and commercial entities like AstraZeneca, to rapidly bring a life-saving product to market.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026   The British-Swedish pharma giant pays $1.2 billion upfront for access to next-generation weight-loss treatment as China patent cliff changes the market.
Europe
INTA: ‘Davos of IP’ will take London meeting to a ‘different level’
5 February 2026   Excitement is mounting for the world’s largest IP gathering, which will see the industry’s elites travelling to the UK in the spring, reveals the association’s CEO.
Careers
Nine-partner litigation team leaves Winston & Strawn
5 February 2026   The trial group, which brings “exceptional litigation talent”, joins larger firm in Texas and Washington, DC, coinciding with the announcement of the Winston Taylor merger.


Editor's picks

AstraZeneca partners with Chinese firm ahead of next obesity race
Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026

Editor's picks

Asia
AstraZeneca partners with Chinese firm ahead of next obesity race
5 February 2026
Europe
Final call: Who are the world’s best in-house counsel?
16 January 2026
Americas
Bayer enters COVID-19 vaccine row with three suits against major drugmakers
8 January 2026
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
16 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025

More features

AstraZeneca partners with Chinese firm ahead of next obesity race
INTA: ‘Davos of IP’ will take London meeting to a ‘different level’
Nine-partner litigation team leaves Winston & Strawn
Squire Patton Boggs brings in tech and data expert as Ireland practice lead
LSPN Awards USA returns for second year—with new categories
Drowning in EU regulations? Five tips for surviving the deluge of new rules
Moderna VP and regulatory expert moves to private practice
Crowell adds tech partner with in-house and private practice expertise